At the Center for the Evaluation of Value and Risk in Health (CEVR), our new projects include:
- CMS Innovation Award to evaluate cloud-based technology in the critical care setting.
- Simulation model to assess vascular access options at hemodialysis initiation.
- The costs and benefits of treatments for treat leukemia, lymphoma, and myeloma.
- Analyzing multiple unmanaged comorbidities in diabetes patients
- Factors influencing Medicare coverage of new technology
- The influence of comparative effectiveness research on coverage and reimbursement
- Modeling the impact of early Alzheimer’s disease detection
Our past projects include:
- Can Medicare identify and pay for high-value and low-value services?
- How framing of health benefits affects the perceived value of cancer treatments;
- Willingness-to-pay for cancer therapies;
- Value-based payment and coverage policies for Medicare;
- The “reassurance value” people place on diagnostic tests
- The projected impact of a tiered, value-based drug formulary
- Value-based formulary policies for specialty medications;
- Opioid abuse risk and optimal REMS policies;
- The quality of care for Medicare beneficiaries with Alzheimer’s disease;
- Drug companies use of FDAMA Section 114
- The quality and performance of Medicare Special Needs Plans.
- The economics of mild cognitive impairment
- Projecting long-term therapeutic benefits for spinal cord injury therapies based on short-term clinical data
- FDA’s regulatory actions against health economic promotions